Home › Companies › Elanco Animal Health Incorporated › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Elanco Animal Health Incorporated’s Form 8-K, filed May 27, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 21, 2026: 7 items on Elanco Animal Health Incorporated’s Form 8-K, filed May 27, 2026: 5 elected · 2 approved.
Significant dissent: 1 director (20.2% against).
Notable dissent: 1 director (19.7% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore Elanco Animal Health Incorporated in the interactive database Compare manager voting policies
These tallies are Elanco Animal Health Incorporated’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 27, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Kapila K. Anand | 375,459,071 | 91,840,502 | 655,918 | -- | 15,365,167 | 80% | Elected | — |
| Elect Director: Paul Herendeen | 441,252,058 | 26,575,629 | 127,804 | -- | 15,365,167 | 94% | Elected | — |
| Elect Director: Michael Harrington | 373,406,333 | 94,421,261 | 127,897 | -- | 15,365,167 | 80% | Elected | — |
| Elect Director: Lawrence Kurzius | 442,964,897 | 24,863,542 | 127,052 | -- | 15,365,167 | 95% | Elected | — |
| Elect Director: Kirk McDonald | 440,842,458 | 26,978,663 | 134,370 | -- | 15,365,167 | 94% | Elected | — |
| 2. The appointment of Ernst & Young LLP as Elanco's independent registered public accounting firm for 2026 | 480,470,647 | 2,611,450 | 238,561 | -- | -- | 99.5% | Approved | — |
| 3. By non-binding vote, the compensation of Elanco's named executive officers | 383,528,222 | 84,173,798 | 253,471 | -- | 15,365,167 | 82% | Approved | — |
Source: Elanco Animal Health Incorporated, Form 8-K, filed with the SEC on May 27, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
501 asset managers disclosed a vote on at least one Elanco Animal Health Incorporated item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 5 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
Prior year: 65.8% for (May 16, 2025 meeting) ▲ 14.5 pts
Description as filed by funds: Election of two Class I director nominees and three Class II director nominees: Class I Nominees: Kapila Anand
Elanco Animal Health Incorporated’s own tally for this item (“Elect Director: Kapila K. Anand”): 375,459,071 for, 91,840,502 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All of the nominees nominated by the Board for director were elected to serve for a one-year term ending at the 2027 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.”
Support: 80% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 112 asset managers below reported 227,799,590 for, 60,795,821 against, 82,174 abstained, 419 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 80,607,952 | 55,461 | 1 | 0 | For |
| Dodge & Cox | 0 | 53,024,253 | 0 | 0 | Against |
| Fidelity | 47,607,816 | 0 | 0 | 0 | For |
| BlackRock | 21,297,832 | 0 | 0 | 0 | For |
| T. Rowe Price | 19,225,859 | 0 | 0 | 0 | For |
| Dimensional | 0 | 6,874,262 | 0 | 0 | Against |
| PRIMECAP Odyssey Funds | 6,081,302 | 0 | 0 | 0 | For |
| Invesco | 5,773,017 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,679,978 | 0 | 0 | 0 | For |
| New York Life | 4,136,001 | 0 | 0 | 0 | For |
| Capitol Series Trust | 3,833,800 | 0 | 0 | 0 | For |
| Charles Schwab | 3,464,624 | 0 | 0 | 0 | For |
| John Hancock | 3,162,137 | 115,338 | 0 | 0 | For |
| Legg Mason | 2,500,000 | 0 | 0 | 0 | For |
| Jackson National | 2,413,843 | 84,314 | 0 | 0 | For |
| Capital Group | 2,164,293 | 0 | 0 | 0 | For |
| Allspring | 2,027,240 | 0 | 0 | 0 | For |
| TIAA | 1,716,585 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,578,540 | 4,781 | 0 | 0 | For |
| Federated Hermes | 1,298,629 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,147,989 | 0 | 0 | 0 | For |
| Empower | 993,235 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 913,260 | 0 | 0 | 0 | For |
| Equitable | 886,395 | 0 | 0 | 0 | For |
| Nuveen | 776,589 | 0 | 0 | 0 | For |
Showing the 25 largest of 112 asset managers. All 112 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Prior year: 94.5% for (May 16, 2025 meeting) ▼ 0.2 pts
Description as filed by funds: Election of two Class I director nominees and three Class II director nominees: Class I Nominees: Paul Herendeen
Elanco Animal Health Incorporated’s own tally for this item (“Elect Director: Paul Herendeen”): 441,252,058 for, 26,575,629 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All of the nominees nominated by the Board for director were elected to serve for a one-year term ending at the 2027 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 112 asset managers below reported 280,823,991 for, 7,771,421 against, 82,173 abstained, 419 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 80,608,100 | 55,314 | 0 | 0 | For |
| Dodge & Cox | 53,024,253 | 0 | 0 | 0 | For |
| Fidelity | 47,607,816 | 0 | 0 | 0 | For |
| BlackRock | 21,297,832 | 0 | 0 | 0 | For |
| T. Rowe Price | 19,225,859 | 0 | 0 | 0 | For |
| Dimensional | 0 | 6,874,262 | 0 | 0 | Against |
| PRIMECAP Odyssey Funds | 6,081,302 | 0 | 0 | 0 | For |
| Invesco | 5,773,017 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,679,978 | 0 | 0 | 0 | For |
| New York Life | 4,136,001 | 0 | 0 | 0 | For |
| Capitol Series Trust | 3,833,800 | 0 | 0 | 0 | For |
| Charles Schwab | 3,464,624 | 0 | 0 | 0 | For |
| John Hancock | 3,162,137 | 115,338 | 0 | 0 | For |
| Legg Mason | 2,500,000 | 0 | 0 | 0 | For |
| Jackson National | 2,413,843 | 84,314 | 0 | 0 | For |
| Capital Group | 2,164,293 | 0 | 0 | 0 | For |
| Allspring | 2,027,240 | 0 | 0 | 0 | For |
| TIAA | 1,716,585 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,578,540 | 4,781 | 0 | 0 | For |
| Federated Hermes | 1,298,629 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,147,989 | 0 | 0 | 0 | For |
| Empower | 993,235 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 913,260 | 0 | 0 | 0 | For |
| Equitable | 886,395 | 0 | 0 | 0 | For |
| Nuveen | 776,589 | 0 | 0 | 0 | For |
Showing the 25 largest of 112 asset managers. All 112 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Election of two Class I director nominees and three Class II director nominees: Class II Nominees: Kirk McDonald
Elanco Animal Health Incorporated’s own tally for this item (“Elect Director: Kirk McDonald”): 440,842,458 for, 26,978,663 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All of the nominees nominated by the Board for director were elected to serve for a one-year term ending at the 2027 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 112 asset managers below reported 280,823,991 for, 7,771,421 against, 82,173 abstained, 419 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 80,608,100 | 55,314 | 0 | 0 | For |
| Dodge & Cox | 53,024,253 | 0 | 0 | 0 | For |
| Fidelity | 47,607,816 | 0 | 0 | 0 | For |
| BlackRock | 21,297,832 | 0 | 0 | 0 | For |
| T. Rowe Price | 19,225,859 | 0 | 0 | 0 | For |
| Dimensional | 0 | 6,874,262 | 0 | 0 | Against |
| PRIMECAP Odyssey Funds | 6,081,302 | 0 | 0 | 0 | For |
| Invesco | 5,773,017 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,679,978 | 0 | 0 | 0 | For |
| New York Life | 4,136,001 | 0 | 0 | 0 | For |
| Capitol Series Trust | 3,833,800 | 0 | 0 | 0 | For |
| Charles Schwab | 3,464,624 | 0 | 0 | 0 | For |
| John Hancock | 3,162,137 | 115,338 | 0 | 0 | For |
| Legg Mason | 2,500,000 | 0 | 0 | 0 | For |
| Jackson National | 2,413,843 | 84,314 | 0 | 0 | For |
| Capital Group | 2,164,293 | 0 | 0 | 0 | For |
| Allspring | 2,027,240 | 0 | 0 | 0 | For |
| TIAA | 1,716,585 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,578,540 | 4,781 | 0 | 0 | For |
| Federated Hermes | 1,298,629 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,147,989 | 0 | 0 | 0 | For |
| Empower | 993,235 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 913,260 | 0 | 0 | 0 | For |
| Equitable | 886,395 | 0 | 0 | 0 | For |
| Nuveen | 776,589 | 0 | 0 | 0 | For |
Showing the 25 largest of 112 asset managers. All 112 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of two Class I director nominees and three Class II director nominees: Class II Nominees: Lawrence Kurzius
Elanco Animal Health Incorporated’s own tally for this item (“Elect Director: Lawrence Kurzius”): 442,964,897 for, 24,863,542 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All of the nominees nominated by the Board for director were elected to serve for a one-year term ending at the 2027 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 112 asset managers below reported 280,823,996 for, 7,771,416 against, 82,173 abstained, 419 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 80,608,105 | 55,309 | 0 | 0 | For |
| Dodge & Cox | 53,024,253 | 0 | 0 | 0 | For |
| Fidelity | 47,607,816 | 0 | 0 | 0 | For |
| BlackRock | 21,297,832 | 0 | 0 | 0 | For |
| T. Rowe Price | 19,225,859 | 0 | 0 | 0 | For |
| Dimensional | 0 | 6,874,262 | 0 | 0 | Against |
| PRIMECAP Odyssey Funds | 6,081,302 | 0 | 0 | 0 | For |
| Invesco | 5,773,017 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,679,978 | 0 | 0 | 0 | For |
| New York Life | 4,136,001 | 0 | 0 | 0 | For |
| Capitol Series Trust | 3,833,800 | 0 | 0 | 0 | For |
| Charles Schwab | 3,464,624 | 0 | 0 | 0 | For |
| John Hancock | 3,162,137 | 115,338 | 0 | 0 | For |
| Legg Mason | 2,500,000 | 0 | 0 | 0 | For |
| Jackson National | 2,413,843 | 84,314 | 0 | 0 | For |
| Capital Group | 2,164,293 | 0 | 0 | 0 | For |
| Allspring | 2,027,240 | 0 | 0 | 0 | For |
| TIAA | 1,716,585 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,578,540 | 4,781 | 0 | 0 | For |
| Federated Hermes | 1,298,629 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,147,989 | 0 | 0 | 0 | For |
| Empower | 993,235 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 913,260 | 0 | 0 | 0 | For |
| Equitable | 886,395 | 0 | 0 | 0 | For |
| Nuveen | 776,589 | 0 | 0 | 0 | For |
Showing the 25 largest of 112 asset managers. All 112 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
Description as filed by funds: Election of two Class I director nominees and three Class II director nominees: Class II Nominees: Michael Harrington
Elanco Animal Health Incorporated’s own tally for this item (“Elect Director: Michael Harrington”): 373,406,333 for, 94,421,261 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All of the nominees nominated by the Board for director were elected to serve for a one-year term ending at the 2027 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.”
Support: 80% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 112 asset managers below reported 227,513,435 for, 61,081,977 against, 82,173 abstained, 419 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 80,578,313 | 85,101 | 0 | 0 | For |
| Dodge & Cox | 0 | 53,024,253 | 0 | 0 | Against |
| Fidelity | 47,607,816 | 0 | 0 | 0 | For |
| BlackRock | 21,297,832 | 0 | 0 | 0 | For |
| T. Rowe Price | 19,225,859 | 0 | 0 | 0 | For |
| Dimensional | 0 | 6,874,262 | 0 | 0 | Against |
| PRIMECAP Odyssey Funds | 6,081,302 | 0 | 0 | 0 | For |
| Invesco | 5,773,017 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,679,978 | 0 | 0 | 0 | For |
| New York Life | 4,136,001 | 0 | 0 | 0 | For |
| Capitol Series Trust | 3,833,800 | 0 | 0 | 0 | For |
| Charles Schwab | 3,464,624 | 0 | 0 | 0 | For |
| John Hancock | 3,162,137 | 115,338 | 0 | 0 | For |
| Legg Mason | 2,500,000 | 0 | 0 | 0 | For |
| Jackson National | 2,413,843 | 84,314 | 0 | 0 | For |
| Capital Group | 2,164,293 | 0 | 0 | 0 | For |
| Allspring | 2,027,240 | 0 | 0 | 0 | For |
| TIAA | 1,716,585 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,578,540 | 4,781 | 0 | 0 | For |
| Federated Hermes | 1,298,629 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,147,989 | 0 | 0 | 0 | For |
| Empower | 993,235 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 913,260 | 0 | 0 | 0 | For |
| Equitable | 886,395 | 0 | 0 | 0 | For |
| Nuveen | 776,589 | 0 | 0 | 0 | For |
Showing the 25 largest of 112 asset managers. All 112 are in the interactive database (link above).
Combines 11 wordings of this item as funds reported it.
82% Approved · of votes cast
Prior year: 53.5% for (May 16, 2025 meeting) ▲ 28.5 pts
Description as filed by funds: Advisory vote on the compensation of the company's named executive officers.
Elanco Animal Health Incorporated’s own tally for this item (“3. By non-binding vote, the compensation of Elanco's named executive officers”): 383,528,222 for, 84,173,798 against — passed, per its Form 8-K filed May 27, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The shareholders approved, by non-binding vote, the compensation of Elanco's named executive officers, by the votes set forth in the table below.”
Support: 82% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 80,663,229 | 185 | 0 | 0 | For |
| Dodge & Cox | 0 | 53,024,253 | 0 | 0 | Against |
| Fidelity | 47,607,816 | 0 | 0 | 0 | For |
| BlackRock | 21,297,832 | 0 | 0 | 0 | For |
| T. Rowe Price | 19,042,661 | 183,198 | 0 | 0 | For |
| Dimensional | 6,874,262 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 6,081,302 | 0 | 0 | 0 | For |
| Invesco | 0 | 5,773,017 | 0 | 0 | Against |
| Bridge Builder Trust | 4,679,978 | 0 | 0 | 0 | For |
| New York Life | 4,073,757 | 62,244 | 0 | 0 | For |
| Capitol Series Trust | 3,833,800 | 0 | 0 | 0 | For |
| Charles Schwab | 3,464,624 | 0 | 0 | 0 | For |
| John Hancock | 3,277,475 | 0 | 0 | 0 | For |
| Legg Mason | 2,500,000 | 0 | 0 | 0 | For |
| Jackson National | 2,498,157 | 0 | 0 | 0 | For |
| Capital Group | 2,164,293 | 0 | 0 | 0 | For |
| Allspring | 2,027,240 | 0 | 0 | 0 | For |
| TIAA | 1,716,585 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,583,321 | 0 | 0 | 0 | For |
| Federated Hermes | 1,298,629 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,147,989 | 0 | 0 | 0 | For |
| Empower | 993,235 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 913,260 | 0 | 0 | 0 | For |
| Equitable | 886,395 | 0 | 0 | 0 | For |
| Nuveen | 776,589 | 0 | 0 | 0 | For |
Fund voting reports, all 110 managers: 228,041,352 for, 60,336,759 against, 82,173 abstained, 419 not voted. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Dodge & Cox | 0 | 64,973,931 | 0 | 0 | Against |
| Fidelity | 45,721,775 | 83,976 | 0 | 0 | For |
| PRIMECAP MANAGEMENT CO/CA/ | 43,001,307 | 0 | 0 | 0 | For |
| T. Rowe Price | 35,201,835 | 274,522 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 11,088,529 | 0 | 0 | 0 | For |
| Black Creek Investment Management Inc. | 10,032,266 | 0 | 0 | 0 | For |
| BlackRock | 9,781,019 | 204,984 | 0 | 0 | For |
| State Street | 9,770,401 | 11,988 | 0 | 0 | For |
| Invesco | 0 | 6,085,653 | 0 | 0 | Against |
| John Hancock | 5,845,286 | 0 | 0 | 0 | For |
| FULLER & THALER ASSET MANAGEMENT, INC. | 5,648,904 | 0 | 0 | 0 | For |
| Clearbridge Investments, LLC | 4,280,789 | 0 | 0 | 0 | For |
| Vanguard | 3,948,333 | 0 | 0 | 0 | For |
| Charles Schwab | 3,931,548 | 0 | 0 | 0 | For |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | 3,475,283 | 0 | 0 | 0 | For |
| JUPITER ASSET MANAGEMENT LTD | 3,427,597 | 0 | 0 | 0 | For |
| Capital Group | 3,408,358 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 2,823,671 | 0 | 0 | 0 | For |
| Allspring | 2,722,177 | 0 | 0 | 0 | For |
| Artemis Investment Management LLP | 0 | 2,623,844 | 0 | 0 | Against |
| Northern Trust | 2,415,533 | 41,845 | 0 | 0 | For |
| SHAPIRO CAPITAL MANAGEMENT LLC | 2,401,559 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 2,265,027 | 0 | 0 | 0 | For |
| Federated Hermes | 2,122,763 | 69,609 | 0 | 0 | For |
| Wellington | 2,174,416 | 0 | 0 | 0 | For |
Institutional-manager reports, all 417 managers: 250,108,579 for, 79,780,290 against, 37 abstained, 143,892 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.5% Approved · of votes cast
Prior year: 99.3% for (May 16, 2025 meeting) ▲ 0.1 pts
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2026.
Elanco Animal Health Incorporated’s own tally for this item (“2. The appointment of Ernst & Young LLP as Elanco's independent registered public accounting firm for 2026”): 480,470,647 for, 2,611,450 against — passed, per its Form 8-K filed May 27, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The shareholders ratified the appointment of Ernst & Young LLP as Elanco's independent registered public accounting firm for 2026, by the votes set forth in the table below.”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 113 asset managers below reported 288,521,273 for, 129,770 against, 82,173 abstained, 419 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 80,608,156 | 55,258 | 0 | 0 | For |
| Dodge & Cox | 53,024,253 | 0 | 0 | 0 | For |
| Fidelity | 47,607,816 | 0 | 0 | 0 | For |
| BlackRock | 21,297,832 | 0 | 0 | 0 | For |
| T. Rowe Price | 19,225,859 | 0 | 0 | 0 | For |
| Dimensional | 6,874,262 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 6,081,302 | 0 | 0 | 0 | For |
| Invesco | 5,773,017 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,679,978 | 0 | 0 | 0 | For |
| New York Life | 4,136,001 | 0 | 0 | 0 | For |
| Capitol Series Trust | 3,833,800 | 0 | 0 | 0 | For |
| Charles Schwab | 3,464,624 | 0 | 0 | 0 | For |
| John Hancock | 3,277,475 | 0 | 0 | 0 | For |
| Legg Mason | 2,500,000 | 0 | 0 | 0 | For |
| Jackson National | 2,498,157 | 0 | 0 | 0 | For |
| Capital Group | 2,164,293 | 0 | 0 | 0 | For |
| Allspring | 2,027,240 | 0 | 0 | 0 | For |
| TIAA | 1,716,585 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,583,321 | 0 | 0 | 0 | For |
| Federated Hermes | 1,298,629 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,147,989 | 0 | 0 | 0 | For |
| Empower | 993,235 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 913,260 | 0 | 0 | 0 | For |
| Equitable | 886,395 | 0 | 0 | 0 | For |
| Nuveen | 776,589 | 0 | 0 | 0 | For |
Showing the 25 largest of 113 asset managers. All 113 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 499,449,583 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 16.15% |
| 2 | Dodge & Cox | 10.62% |
| 3 | Fidelity | 9.53% |
| 4 | BlackRock | 4.26% |
| 5 | T. Rowe Price | 3.85% |
| 6 | Dimensional | 1.38% |
| 7 | PRIMECAP Odyssey Funds | 1.22% |
| 8 | Invesco | 1.16% |
| 9 | Bridge Builder Trust | 0.94% |
| 10 | New York Life | 0.83% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Dodge & Cox | 13.01% |
| 2 | Fidelity | 9.17% |
| 3 | PRIMECAP MANAGEMENT CO/CA/ | 8.61% |
| 4 | T. Rowe Price | 7.10% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 2.22% |
| 6 | Black Creek Investment Management Inc. | 2.01% |
| 7 | BlackRock | 2.00% |
| 8 | State Street | 1.96% |
| 9 | Invesco | 1.22% |
| 10 | John Hancock | 1.17% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Dodge & Cox | 68,944,100 | 13.80% | Schedule 13G, filed May 14, 2026 |
| FMR LLC | 52,196,321 | 10.45% | Proxy statement (DEF 14A), table as of March 26, 2026 |
| FMR (Fidelity) | 50,925,366 | 10.20% | Form 13F, quarter ended March 31, 2026 |
| Vanguard Group | 48,059,731 | 9.62% | Form 13F, quarter ended March 31, 2026 |
| BlackRock | 47,622,630 | 9.54% | Form 13F, quarter ended March 31, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | 45,840,956 | 9.18% | Schedule 13G, filed May 13, 2026 |
| T. Rowe Price Investment Management, Inc. | 31,547,970 | 6.32% | Proxy statement (DEF 14A), table as of March 26, 2026 |
| Dimensional Fund Advisors LP | 25,082,545 | 5.02% | Proxy statement (DEF 14A), table as of March 26, 2026 |
| State Street | 15,336,479 | 3.07% | Form 13F, quarter ended March 31, 2026 |
| Morgan Stanley | 8,286,608 | 1.66% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 499,449,583 shares outstanding, as reported by Elanco Animal Health Incorporated on its Form 10-Q dated May 1, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Elanco Animal Health Incorporated's shareholder meeting held May 21, 2026, in the 2025-2026 proxy season, 501 asset managers reported votes on at least one of its 7 ballot items in their SEC Form N-PX filings, covering 4,257 separate fund positions. On the most widely held item on that ballot — Advisory vote on the compensation of the company's named executive officers. — Elanco Animal Health Incorporated's filing reports the proposal as approved, with 82% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Elanco Animal Health Incorporated's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 27, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Elanco Animal Health Incorporated’s 10-Q dated May 1, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Elanco Animal Health Incorporated proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Elanco Animal Health (ELAN) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/elanco-animal-health-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.